Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Recommended
AI use in schools: How districts are making sure it's used as a study aid
Recommended
What to know about Labor Day and its history
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Zomedica Pharmaceuticals Corp
(NY:
ZOM
)
0.1288
+0.0023 (+1.82%)
Streaming Delayed Price
Updated: 2:06 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Zomedica Pharmaceuticals Corp
< Previous
1
2
3
4
Next >
Zomedica's Assisi Loop(R) Product Line Designated as Fear Free(TM) Preferred Product
August 29, 2024
Via
ACCESSWIRE
Zomedica Introduces Enhanced Audio Features for the VETGuardian(R) Zero-touch Vital Signs Remote Monitoring System
August 22, 2024
Via
ACCESSWIRE
Zomedica Announces Key Educational Presentations at Fetch dvm360 Veterinary Conference
August 20, 2024
Via
ACCESSWIRE
Zomedica Announces Second Quarter 2024 Financial Results: Revenue of $6.1 Million; 71% Gross Margin, and $83.0 Million in Liquidity to Support Growth
August 14, 2024
Via
ACCESSWIRE
Zomedica Continues Global Expansion Through Strategic Partnership with SIRE Veterinario, S.A for Sales Expansion in Central America
August 14, 2024
Via
ACCESSWIRE
Zomedica to Report Second Quarter 2024 Financial Results and Provide Business Update on August 14 at 4:30 p.m. ET
August 01, 2024
Via
ACCESSWIRE
The United States Eventing Association Names Zomedica’s PulseVet(R) as the Official Shock Wave of the USEA
July 17, 2024
Via
ACCESSWIRE
US Equestrian Names Zomedica’s PulseVet System as the Official Shock Wave Therapy of US Equestrian Team Veterinarians
July 01, 2024
Via
ACCESSWIRE
Zomedica Expands TRUFORMA Addressable Market with Launch of Equine Cortisol Assay for the Platform
June 27, 2024
Via
ACCESSWIRE
Zomedica Expands Market Opportunity for the TRUFORMA Point-of-Care Diagnostic Platform by Securing CE Mark
June 25, 2024
Via
ACCESSWIRE
Zomedica Expands Global Reach Through Strategic Alliance with Leader Healthcare Group for Sales Expansion in Key International Markets
July 09, 2024
Via
ACCESSWIRE
Sidoti Events, LLC's Virtual June Small-Cap Conference
June 11, 2024
Via
ACCESSWIRE
Zomedica to Present at the Sidoti Small Cap Conference June 12, 2024
June 10, 2024
Via
ACCESSWIRE
Zomedica Announces Presentation of Compelling TRUFORMA(R) Research Findings and Educational Programs at Major Veterinary Internal Medicine Conference
June 06, 2024
Via
ACCESSWIRE
Zomedica Increases Manufacturing Capacity with Expansion of its Roswell, Georgia Facility; Can Support Production to Five times Current Levels
June 04, 2024
Via
ACCESSWIRE
Zomedica Enhances TRUFORMA(R) Platform With Launch of Advanced Canine Cortisol Assay
May 29, 2024
Via
ACCESSWIRE
Zomedica Publishes White Paper Highlighting Expanded Market Opportunities for PulseVet(R) Therapy
May 23, 2024
Via
ACCESSWIRE
Zomedica Releases Over-the-Air Software Update Capabilities for Its TRUFORMA(R) Platform
May 15, 2024
Via
ACCESSWIRE
Zomedica Announces First Quarter 2024 Financial Results: Revenue up 14% to $6.3 Million; 66% Gross Margin, and $91 Million in Liquidity
May 09, 2024
Via
ACCESSWIRE
Zomedica to Present at the Lytham Partners Spring 2024 Investor Conference on May 30, 2024
May 21, 2024
Via
ACCESSWIRE
Zomedica to Present at the EF Hutton Annual Global Conference on May 15, 2024
May 08, 2024
Via
ACCESSWIRE
Zomedica Corp. (NYSE American: ZOM) Featured in Coverage of the EF Hutton Annual Global Conference
May 06, 2024
Via
Investor Brand Network
Zomedica Expands International Reach with CE Certification for VetGuardian(R) System
May 06, 2024
Via
ACCESSWIRE
Zomedica Strengthens Market Position with New Patents Issued for its TRUFORMA(R) Diagnostic Platform
May 02, 2024
Via
ACCESSWIRE
Zomedica to Report First Quarter 2024 Financial Results and Provide Business Update on May 9th at 4:30 p.m. ET
April 30, 2024
Via
ACCESSWIRE
Zomedica to Present at the Noble Capital Markets Virtual Healthcare Conference on April 17, 2024
April 09, 2024
Via
ACCESSWIRE
Zomedica Reports Record Revenue of $7.3 Million for the Fourth Quarter and $25.2 Million for the Full Year 2023, Reflecting 33% Annual Growth; 69% Gross Margin and $100.5 Million in Liquidity
April 01, 2024
Via
ACCESSWIRE
Zomedica to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Monday, April 1, 2024, at 4:30 p.m. ET
March 20, 2024
Via
ACCESSWIRE
Zomedica Announces Publication of Research Concluding TRUFORMA(R) Platform is More Accurate Diagnostic Test for Feline Hyperthyroidism than Chemiluminescent Immunoassay (CLIA) Platform
March 14, 2024
Via
ACCESSWIRE
Zomedica Provides NYSE American Listing Update
March 13, 2024
Via
ACCESSWIRE
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.